BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10442079)

  • 1. Ultrasound in musculoskeletal tumors with emphasis on its role in tumor follow-up.
    Van der Woude HJ; Vanderschueren G
    Radiol Clin North Am; 1999 Jul; 37(4):753-66. PubMed ID: 10442079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/Computed Tomography and Precision Medicine: Musculoskeletal Sarcoma.
    Kandathil A; Subramaniam RM
    PET Clin; 2017 Oct; 12(4):475-488. PubMed ID: 28867117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of malignant and benign musculoskeletal tumors: combined color and power Doppler US and spectral wave analysis.
    Bodner G; Schocke MF; Rachbauer F; Seppi K; Peer S; Fierlinger A; Sununu T; Jaschke WR
    Radiology; 2002 May; 223(2):410-6. PubMed ID: 11997546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing ultrasound-guided biopsy of musculoskeletal masses by application of an ultrasound contrast agent.
    Loizides A; Widmann G; Freuis T; Peer S; Gruber H
    Ultraschall Med; 2011 Jun; 32(3):307-10. PubMed ID: 20938892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Color Doppler controlled needle biopsy in diagnosis of soft tissue and bone tumors].
    Schulte M; Heymer B; Sarkar MR; Negri G; von Baer A; Hartwig E
    Chirurg; 1998 Oct; 69(10):1059-67. PubMed ID: 9833186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of 2-dimentional ultrasonography and color Doppler flow imaging in primary bone tumor].
    Liu XM; Wang WC; Liu MH; Zhou QC
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):420-3. PubMed ID: 16859139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound of musculoskeletal soft-tissue tumors superficial to the investing fascia.
    Hung EH; Griffith JF; Ng AW; Lee RK; Lau DT; Leung JC
    AJR Am J Roentgenol; 2014 Jun; 202(6):W532-40. PubMed ID: 24848846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
    Jones DN; McCowage GB; Sostman HD; Brizel DM; Layfield L; Charles HC; Dewhirst MW; Prescott DM; Friedman HS; Harrelson JM; Scully SP; Coleman RE
    J Nucl Med; 1996 Sep; 37(9):1438-44. PubMed ID: 8790188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-of-the-art HR-US imaging findings of the most frequent musculoskeletal soft-tissue tumors.
    Widmann G; Riedl A; Schoepf D; Glodny B; Peer S; Gruber H
    Skeletal Radiol; 2009 Jul; 38(7):637-49. PubMed ID: 18846371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and referral of musculoskeletal tumors].
    Zamora T; Burdiles Á; Botello E
    Rev Med Chil; 2022 Oct; 150(10):1361-1369. PubMed ID: 37358095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-directed color Doppler ultrasonography in the evaluation of superficial solid tumors.
    Ozbek SS; Arkun R; Killi R; Memiş A; Dağdeviren A; Sevinç E
    J Clin Ultrasound; 1995 May; 23(4):233-8. PubMed ID: 7797660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumors of suspected adnexal origin.
    Valentin L
    Eur J Obstet Gynecol Reprod Biol; 1997 Mar; 72(1):63-72. PubMed ID: 9076424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
    Yapar Z; Kibar M; Ozbarlas S; Yapar AF; Uguz A; Zorludemir S; Herdem M
    Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttreatment Imaging in Orthopedic Oncology.
    Watts V GJ; Zoga AC; Abraham JA
    Semin Roentgenol; 2017 Oct; 52(4):291-300. PubMed ID: 28965548
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiation of benign and malignant superficial soft-tissue masses using grayscale and color doppler ultrasonography.
    Chiou HJ; Chou YH; Chiu SY; Wang HK; Chen WM; Chen TH; Chang CY
    J Chin Med Assoc; 2009 Jun; 72(6):307-15. PubMed ID: 19541566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [General diagnostic work-up for benign tumors of the musculoskeletal system].
    Panotopoulos J; Funovics PT; Windhager R
    Orthopade; 2017 Jun; 46(6):473-476. PubMed ID: 28444414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of ultrasound of musculoskeletal soft-tissue tumors.
    Bui-Mansfield LT; Chen DC; O'Brien SD
    AJR Am J Roentgenol; 2015 Feb; 204(2):W218. PubMed ID: 25615787
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to "accuracy of ultrasound of musculoskeletal soft-tissue tumors".
    Hung EH; Griffith JF
    AJR Am J Roentgenol; 2015 Feb; 204(2):W219. PubMed ID: 25615788
    [No Abstract]   [Full Text] [Related]  

  • 20. Perfusion MR imaging at 3-Tesla: Can it predict tumor grade and histologic necrosis rate of musculoskeletal sarcoma?
    Gondim Teixeira PA; Renaud A; Aubert S; Ben Haj Amor M; Robin YM; Cotten A; Ceugnart L
    Diagn Interv Imaging; 2018; 99(7-8):473-481. PubMed ID: 29571698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.